These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37965684)

  • 1. Multiply robust causal inference of the restricted mean survival time difference.
    Shu D; Mukhopadhyay S; Uno H; Gerber JS; Schaubel DE
    Stat Methods Med Res; 2023 Dec; 32(12):2386-2404. PubMed ID: 37965684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust causal inference of drug-drug interactions.
    Shu D; Han P; Hennessy S; Miano TA
    Stat Med; 2023 Mar; 42(7):970-992. PubMed ID: 36627826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the marginal hazard ratio by simultaneously using a set of propensity score models: A multiply robust approach.
    Shu D; Han P; Wang R; Toh S
    Stat Med; 2021 Feb; 40(5):1224-1242. PubMed ID: 33410157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiply robust estimator for the difference in survival functions using pseudo-observations.
    Wang C; Wei K; Huang C; Yu Y; Qin G
    BMC Med Res Methodol; 2023 Oct; 23(1):247. PubMed ID: 37872495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propensity weighting plus adjustment in proportional hazards model is not doubly robust.
    Gabriel EE; Sachs MC; Waernbaum I; Goetghebeur E; Blanche PF; Vansteelandt S; Sjölander A; Scheike T
    Biometrics; 2024 Jul; 80(3):. PubMed ID: 39036984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alternative empirical likelihood method in missing response problems and causal inference.
    Ren K; Drummond CA; Brewster PS; Haller ST; Tian J; Cooper CJ; Zhang B
    Stat Med; 2016 Nov; 35(27):5009-5028. PubMed ID: 27417265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiply robust estimation of causal quantile treatment effects.
    Xie Y; Cotton C; Zhu Y
    Stat Med; 2020 Dec; 39(28):4238-4251. PubMed ID: 32857876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model misspecification and robustness in causal inference: comparing matching with doubly robust estimation.
    Waernbaum I
    Stat Med; 2012 Jul; 31(15):1572-81. PubMed ID: 22359267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double Robust Efficient Estimators of Longitudinal Treatment Effects: Comparative Performance in Simulations and a Case Study.
    Tran L; Yiannoutsos C; Wools-Kaloustian K; Siika A; van der Laan M; Petersen M
    Int J Biostat; 2019 Feb; 15(2):. PubMed ID: 30811344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse probability of treatment weighting with generalized linear outcome models for doubly robust estimation.
    Gabriel EE; Sachs MC; Martinussen T; Waernbaum I; Goetghebeur E; Vansteelandt S; Sjölander A
    Stat Med; 2024 Feb; 43(3):534-547. PubMed ID: 38096856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doubly Robust Additive Hazards Models to Estimate Effects of a Continuous Exposure on Survival.
    Wang Y; Lee M; Liu P; Shi L; Yu Z; Abu Awad Y; Zanobetti A; Schwartz JD
    Epidemiology; 2017 Nov; 28(6):771-779. PubMed ID: 28832358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving causal inference with a doubly robust estimator that combines propensity score stratification and weighting.
    Linden A
    J Eval Clin Pract; 2017 Aug; 23(4):697-702. PubMed ID: 28116816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model misspecification and bias for inverse probability weighting estimators of average causal effects.
    Waernbaum I; Pazzagli L
    Biom J; 2023 Feb; 65(2):e2100118. PubMed ID: 36045099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis.
    Austin PC
    Stat Med; 2016 Dec; 35(30):5642-5655. PubMed ID: 27549016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Restricted Mean Survival Time Based Methods and Traditional Survival Methods: An Application in an Oncological Data.
    Huang Q; Tian C
    Comput Math Methods Med; 2022; 2022():7264382. PubMed ID: 36619796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes.
    Austin PC; Stuart EA
    Stat Methods Med Res; 2017 Aug; 26(4):1654-1670. PubMed ID: 25934643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-computation and doubly robust standardisation for continuous-time data: A comparison with inverse probability weighting.
    Chatton A; Borgne FL; Leyrat C; Foucher Y
    Stat Methods Med Res; 2022 Apr; 31(4):706-718. PubMed ID: 34861799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved multiply robust estimator for the average treatment effect.
    Wang C; Wei K; Huang C; Yu Y; Qin G
    BMC Med Res Methodol; 2023 Oct; 23(1):231. PubMed ID: 37821829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing Extreme Propensity Scores in Estimating Counterfactual Survival Functions via the Overlap Weights.
    Cheng C; Li F; Thomas LE; Li FF
    Am J Epidemiol; 2022 May; 191(6):1140-1151. PubMed ID: 35238335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.
    Austin PC; Stuart EA
    Stat Med; 2015 Dec; 34(28):3661-79. PubMed ID: 26238958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.